Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neurocognitive Disorders: later-stage trial registry
4 of 9 indexed Neurocognitive Disorders trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Neurocognitive Disorders: 9 US clinical trials tracked, 4 recruiting.
Neurocognitive Disorders is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Michigan, running 2 of these trials.
Enrollment posture brief
Registry condition neurocognitive-disorders
OPEN 4 | RECR 44% | LATE 2 | EARLY 0 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)
Neurocognitive Disorders lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neurocognitive Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neurocognitive Disorders is recruiting below its size-band peers.
4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Neurocognitive Disorders research.
University of Michigan accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Neurocognitive Disorders enrolment sits around 80 participants.
Median target enrolment is 80 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.
-
Neurocognitive Disorders splits between interventional and observational designs.
5 interventional and 4 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
University of Michigan
NCT05929703
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
Oregon Health and Science University
NCT06036095
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
Baptist Health South Florida
NCT05504681
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Mclean Hospital
NCT05245903
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
Eli Lilly and Company
NCT05738486
Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers
Elizabeth K Rhodus
NCT05202223
Development of the Pediatric Neurocognitive Functioning Questionnaire
St. Jude Children's Research Hospital
NCT03213431
Postoperative Neurocognitive Disorders
Massachusetts General Hospital
NCT04244162
A Pilot Randomized Controlled Trial: CoINTEGRATE
University of Michigan
NCT05732285
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Neurocognitive Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neurocognitive Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neurocognitive Disorders page
9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Neurocognitive Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Michigan sponsors the most Neurocognitive Disorders trials on record, review their full trial history before evaluating a specific study. See University of Michigan's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurocognitive Disorders condition card totals 9 registered trials; most-linked intervention Blood Biomarkers; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.